Inspiration Healthcare Group (LSE:IHC) EBITDA Margin %: 2.47% (As of Jan. 2026) — 69% Below Median


LSE:IHC Inspiration Healthcare Group PLC LSE:IHC
48 GF Score
Price £0.23
GF Value £0.22
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Inspiration Healthcare Group EBITDA Margin %?

Inspiration Healthcare Group LSE:IHC 48 EBITDA Margin % is 2.47% as of Jan. 2026, which is 69% below its 10-year median of 7.97. GuruFocus rates LSE:IHC with a GF Score™ of 48/100 and a GF Value™ of £0.22 (Fairly Valued). The stock has 6 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Inspiration Healthcare Group ranks worse than 56.86% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Inspiration Healthcare Group's EBITDA for the six months ended in Jan. 2026 was £0.58 Mil. Inspiration Healthcare Group's Revenue for the six months ended in Jan. 2026 was £23.56 Mil. Therefore, Inspiration Healthcare Group's EBITDA margin for the quarter that ended in Jan. 2026 was 2.47%.


Inspiration Healthcare Group  (LSE:IHC) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Inspiration Healthcare Group EBITDA Margin % Related Terms


Inspiration Healthcare Group EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Inspiration Healthcare Group's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inspiration Healthcare Group EBITDA Margin % Chart

Inspiration Healthcare Group Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.03 6.68 -6.45 -32.53 3.75

Inspiration Healthcare Group Semi-Annual Data
Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24 Jul24 Jan25 Jul25 Jan26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -21.58 -12.64 -48.51 5.01 2.47

LSE:IHC vs ABT, SYK, MDT: EBITDA Margin % Comparison

For the Medical Devices subindustry, Inspiration Healthcare Group's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inspiration Healthcare Group EBITDA Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Inspiration Healthcare Group's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Inspiration Healthcare Group's EBITDA Margin % falls into.


LSE:IHC
48GF Score
Inspiration Healthcare Group PLC LSE:IHC
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Inspiration Healthcare Group EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Inspiration Healthcare Group's EBITDA Margin % for the fiscal year that ended in Jan. 2026 is calculated as

EBITDA Margin %=EBITDA (A: Jan. 2026 )/Revenue (A: Jan. 2026 )
=1.782/47.547
=3.75 %

Inspiration Healthcare Group's EBITDA Margin % for the quarter that ended in Jan. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Jan. 2026 )/Revenue (Q: Jan. 2026 )
=0.581/23.559
=2.47 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 2.47% mean?
Inspiration Healthcare Group (LSE:IHC) has a EBITDA Margin % of 2.47% as of Jan. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Inspiration Healthcare Group and its competitors. This is 69% below median its historical median of 7.97. According to the industry distribution chart, Inspiration Healthcare Group ranks #464 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 56.9%.
Is Inspiration Healthcare Group's EBITDA Margin % too high?
Inspiration Healthcare Group's current EBITDA Margin % of 2.47% is 69% below median its 10-year median of 7.97. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. Inspiration Healthcare Group's value of 2.47% is 67% below this industry median. Based on the distribution chart, Inspiration Healthcare Group ranks #464 out of 816 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Inspiration Healthcare Group has a GF Score™ of 48/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Inspiration Healthcare Group's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Inspiration Healthcare Group ranks #464 out of 816 companies for EBITDA Margin %. This places Inspiration Healthcare Group in the lower half of its industry. The industry median EBITDA Margin % is 7.48. Inspiration Healthcare Group's value of 2.47% is 67% below this benchmark. While the company's 10-year median is 7.97 vs. the industry median of 7.48, Inspiration Healthcare Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Inspiration Healthcare Group's current EBITDA Margin % of 2.47% is 67% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Inspiration Healthcare Group and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Inspiration Healthcare Group's current EBITDA Margin % is 2.47%, which is 69% below median its own 10-year median of 7.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inspiration Healthcare Group stock overvalued right now?
Based on GuruFocus' analysis, Inspiration Healthcare Group (LSE:IHC) is currently considered Fairly Valued. The stock's GF Value™ is £0.22, compared to a current price of £0.23 — trading 2.3% above its estimated fair value. The current EBITDA Margin % is 2.47%, which is 69% below median its 10-year median of 7.97 and 67% below the Medical Devices & Instruments industry median of 7.48. Inspiration Healthcare Group's overall GF Score™ is 48/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Inspiration Healthcare Group (LSE:IHC), the current EBITDA Margin % is 2.47% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Inspiration Healthcare Group (LSE:IHC) Overvalued in 2026?

Based on GuruFocus' analysis, Inspiration Healthcare Group stock appears to be overvalued. The current stock price of £0.23 is trading 2.3% above its estimated GF Value™ of £0.22. GuruFocus considers Inspiration Healthcare Group to be Fairly Valued.

Key valuation signals for LSE:IHC:

  • EBITDA Margin %: 2.47% (69% below median its 10-year median of 7.97)
  • GF Value™: £0.22 vs. price of £0.23 (2.3% above fair value)
  • GF Score™: 48/100 with 6 warning signs
  • Industry Position: 67% below the Medical Devices & Instruments median (#464 of 816)

No single metric tells the full story. See the LSE:IHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Inspiration Healthcare Group Business Description

Address Unit 7/8 Commerce Park, Commerce Way, Croydon, GBR, CR0 4YL
Inspiration Healthcare Group PLC supplies outcome-improving medical devices in the areas of neonatal intensive care and patient warming. It operates in the Critical Care Medical Devices segment which includes Critical Care, Operating Theatre, and Home Healthcare. The company derives the maximum of its revenue from the United Kingdom through the Critical Care market division.
48GF Score

Get the complete analysis for LSE:IHC

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.23
Price
£0.22
GF Value